Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 07, 2024

SELL
$0.6 - $1.31 $32,065 - $70,009
-53,442 Reduced 25.71%
154,456 $132,000
Q3 2023

Nov 09, 2023

SELL
$1.05 - $3.37 $242,166 - $777,239
-230,635 Reduced 52.59%
207,898 $222,000
Q2 2023

Aug 09, 2023

SELL
$2.44 - $4.53 $61,890 - $114,903
-25,365 Reduced 5.47%
438,533 $1.14 Million
Q1 2023

May 12, 2023

SELL
$3.72 - $5.4 $312,357 - $453,421
-83,967 Reduced 15.33%
463,898 $1.89 Million
Q4 2022

Feb 09, 2023

SELL
$3.41 - $12.93 $818,205 - $3.1 Million
-239,943 Reduced 30.46%
547,865 $2.75 Million
Q3 2022

Nov 10, 2022

BUY
$12.59 - $17.67 $1.78 Million - $2.49 Million
141,090 Added 21.82%
787,808 $10.3 Million
Q2 2022

Aug 12, 2022

BUY
$10.58 - $17.5 $924,469 - $1.53 Million
87,379 Added 15.62%
646,718 $8.29 Million
Q1 2022

May 13, 2022

BUY
$13.81 - $18.6 $1.74 Million - $2.34 Million
125,732 Added 29.0%
559,339 $8.53 Million
Q4 2021

Feb 09, 2022

BUY
$17.26 - $22.02 $3.31 Million - $4.23 Million
191,886 Added 79.38%
433,607 $7.68 Million
Q3 2021

Nov 12, 2021

BUY
$20.15 - $26.19 $2.3 Million - $2.99 Million
114,164 Added 89.5%
241,721 $5.08 Million
Q2 2021

Aug 12, 2021

SELL
$15.06 - $30.03 $266,667 - $531,741
-17,707 Reduced 12.19%
127,557 $2.52 Million
Q1 2021

May 14, 2021

BUY
$24.99 - $31.93 $1.86 Million - $2.37 Million
74,332 Added 104.79%
145,264 $4.21 Million
Q4 2020

Feb 25, 2021

BUY
$16.21 - $31.44 $1.15 Million - $2.23 Million
70,932 New
70,932 $2.15 Million

Others Institutions Holding NGM

About NGM BIOPHARMACEUTICALS INC


  • Ticker NGM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 80,365,904
  • Description
  • NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...
More about NGM
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.